PRA-052

N/A

Report date: 2026/04/22 20:01:10

Base Information

Drug NamePRA-052
Drug Alias NamePRA-052MK-8690PR-600
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionTumor necrosis factor receptor superfamily member 8 inhibitors
TargetsTumor necrosis factor receptor superfamily member 8
Therapy Area/IndicationsColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPrometheus Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesDr Falk Pharma GmbHMerck Sharp & Dohme LLCPrometheus Biosciences Inc
Inactive CompaniesN/A
Active IndicationsColitis, Ulcerative
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A